This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Article

A Cluster of Cholesterol-Related Genes Confers Susceptibility for Alzheimer’s Disease

Andreas Papassotiropoulos, MD; M. Axel Wollmer, MD; Magdalini Tsolaki, MSc; Fabienne Brunner, MSc; Dimitra Molyva, MSc; Dieter Lütjohann, PhD; Roger M. Nitsch, MD; and Christoph Hock, MD

Published: July 15, 2005

Article Abstract

Objective: Polygenic diseases are related to the complex interplay of genetic variations. We evaluated whether clusters of cholesterol- and lipid-related genetic variations are associated with Alzheimer’s disease.

Method: We analyzed 12 cholesterol-related single nucleotide polymorphisms and 48 control polymorphisms in 545 study participants (Alzheimer’s disease group N = 284; control group N = 261). Diagnoses of Alzheimer’s disease were made according to the NINCDS-ADRDA criteria. Multi-locus genetic association analysis was done with the set-association method. Dates of data collection were from January 2000 to December 2003.

Results: We identified a cluster of polymorphisms in APOE, SOAT1, APOE 5′-untranslated region, OLR1, CYP46A1, LPL, LIPA, and APOA4 conferring significant (p = .0002) susceptibility for Alzheimer’s disease. This gene cluster reached a diagnostic accuracy of 74% and correlated significantly (p = .018) with the levels of the brain cholesterol catabolite 24S-hydroxycholesterol in the cerebrospinal fluid.

Conclusion: Our results establish a novel approach for the identification of disease-related genetic clusters and demonstrate the need for multi-locus methods in the genetics of complex diseases.

Volume: 66

Quick Links: Dementia , Neurologic and Neurocognitive

Continue Reading…

Subscribe to read the entire article

$40.00

Buy this Article as a PDF